GLIADEL Side Effects

6992160-3 | Back Pain, Lung Neoplasm, Malignant Pleural Effusion, Metastases To Lung, Pneumonia, Respiratory Distress, Respiratory Failure, Sepsis
on Aug 13, 2010 Female patient from UNITED STATES , 51 years of age, was diagnosed with gliosarcoma and was treated with Gliadel (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), lung neoplasm, malignant pleural effusion, metastases to lung, pneumonia (What is pneumonia?), respiratory distress, respiratory failure, sepsis (What is sepsis?). Gliadel dosage: .

6988355-5 | Cellulitis
Patient was taking Gliadel (View Usage). Patient had the following side effects: cellulitis (What is cellulitis?) on Sep 02, 2010 from UNITED STATES Additional patient health information: Female patient , 30 years of age, was diagnosed with glioblastoma multiforme and. Gliadel dosage: . Patient was hospitalized.

6987849-6 | Brain Abscess, Osteitis
Adverse event was reported on Sep 02, 2010 by a Female patient taking Gliadel (View Usage) (Dosage: ) was diagnosed with glioblastoma multiforme and. Location: UNITED STATES , 44 years of age, After Gliadel was administered, patient had the following side effects: brain abscess, osteitis. Patient was hospitalized.

6987792-2 | Brain Abscess, Osteitis
on Sep 02, 2010 Female patient from UNITED STATES , 57 years of age, was diagnosed with glioblastoma multiforme and was treated with Gliadel (View Usage). Patient experienced the following unwanted or unexpected effects: brain abscess, osteitis. Gliadel dosage: . Patient was hospitalized.


6987791-0 | Brain Abscess, Osteitis
on Sep 02, 2010 Female patient from UNITED STATES , 38 years of age, was diagnosed with glioblastoma multiforme and was treated with Gliadel (View Usage). Patient had the following side effects: brain abscess, osteitis. Gliadel dosage: . Patient was hospitalized.

6987215-3 | Brain Abscess, Osteitis
Patient was taking Gliadel (View Usage). After Gliadel was administered, patient had the following side effects: brain abscess, osteitis on Sep 02, 2010 from UNITED STATES Additional patient health information: Female patient , 34 years of age, was diagnosed with glioblastoma and. Gliadel dosage: . Patient was hospitalized.

6978406-6 | Brain Oedema, Facial Paresis, Headache, Hemianopia Homonymous, Hemiparesis, Mood Altered, Sensory Loss, Somnolence, Vomiting
Adverse event was reported on Sep 02, 2010 by a Female patient taking Gliadel (View Usage) (Dosage: ) was diagnosed with glioblastoma multiforme and. Location: UNITED STATES , 53 years of age, Patient experienced the following unwanted or unexpected effects: brain oedema, facial paresis, headache (What is headache?), hemianopia homonymous, hemiparesis, mood altered, sensory loss, somnolence, vomiting. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).

6977979-7 | Headache, Intraventricular Haemorrhage, Pneumonia Aspiration, Vomiting
on Sep 03, 2010 Male patient from UNITED STATES , 64 years of age, weighting 175.7 lb, was diagnosed with glioblastoma and was treated with Gliadel (View Usage). Patient had the following side effects: headache (What is headache?), intraventricular haemorrhage, pneumonia aspiration, vomiting. Gliadel dosage: . During the same period patient was treated with KEPPRA (View Keppra Review and Keppra Label ), FLOMAX (View Flomax Review and Flomax Label ), LOVENOX (View Lovenox Review and Lovenox Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ), DECADRON (View Decadron Review and Decadron Label ). Patient was hospitalized.

6944724-0 | Brain Mass
on Aug 19, 2010 Female patient from UNITED STATES , 25 years of age, was diagnosed with astrocytoma and was treated with Gliadel (View Usage). After Gliadel was administered, patient had the following side effects: brain mass. Gliadel dosage: .

6933806-5 | Multi-organ Failure
Patient was taking Gliadel (View Usage). Patient experienced the following unwanted or unexpected effects: multi-organ failure on Aug 12, 2010 from UNITED STATES Additional patient health information: Female patient , 75 years of age, . Gliadel dosage: .

6887001-9 | Aggression, Agitation, Oedema, Paresis
Adverse event was reported on Jul 21, 2010 by a Male patient taking Gliadel (View Usage) (Dosage: ) . Location: SPAIN , 58 years of age, Patient had the following side effects: aggression, agitation, oedema, paresis. Patient was hospitalized.

6819016-0 | Inflammation, Pulmonary Embolism
on Jun 25, 2010 Male patient from UNITED STATES , weighting 229.3 lb, was diagnosed with brain cancer metastatic, prophylaxis, hypertension and was treated with Gliadel (View Usage). After Gliadel was administered, patient had the following side effects: inflammation, pulmonary embolism (What is pulmonary embolism?). Gliadel dosage: . During the same period patient was treated with KEPPRA (View Keppra Review and Keppra Label ), PROTONIX (View Protonix Review and Protonix Label ), HYDROCHLOROTHIAZIDE (20/12.5mg) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), VITAMIN B50 (View Vitamin B50 Review and Vitamin B50 Label ), ESTER C (View Ester-c Review and Ester-c Label ), GLUCOSAMINE (View Glucosamine Review and Glucosamine Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ), LOVAZA (View Lovaza Review and Lovaza Label ). Patient was hospitalized and became disabled.

6727885-8 | Metastases To Lung
on May 07, 2010 Female patient from UNITED STATES , 51 years of age, was diagnosed with gliosarcoma and was treated with Gliadel (View Usage). Patient experienced the following unwanted or unexpected effects: metastases to lung. Gliadel dosage: . Patient was hospitalized.

6694642-0 | Anaemia, Brain Mass, Inflammation, Muscular Weakness, Pulmonary Embolism
Patient was taking Gliadel (View Usage). Patient had the following side effects: anaemia, brain mass, inflammation, muscular weakness, pulmonary embolism (What is pulmonary embolism?) on Apr 19, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 229.3 lb, was diagnosed with brain cancer metastatic, prophylaxis, hypertension and. Gliadel dosage: . During the same period patient was treated with KEPPRA (View Keppra Review and Keppra Label ), PROTONIX (View Protonix Review and Protonix Label ), HYDROCHLOROTHIAZIDE (20/12.5mg) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), VITAMIN B50 (View Vitamin B50 Review and Vitamin B50 Label ), ESTER C (View Ester-c Review and Ester-c Label ), GLUCOSAMINE (View Glucosamine Review and Glucosamine Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ), LOVAZA (View Lovaza Review and Lovaza Label ). Patient was hospitalized and became disabled.

6684975-6 | Anaemia, Brain Mass, Muscular Weakness, Pulmonary Embolism
Adverse event was reported on Apr 09, 2010 by a Male patient taking Gliadel (View Usage) (Dosage: ) was diagnosed with brain cancer metastatic, prophylaxis, hypertension and. Location: UNITED STATES , weighting 229.3 lb, After Gliadel was administered, patient had the following side effects: anaemia, brain mass, muscular weakness, pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with KEPPRA (View Keppra Review and Keppra Label ), PROTONIX (View Protonix Review and Protonix Label ), HYDROCHLOROTHIAZIDE (20/12.5mg) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), VITAMIN B50 (View Vitamin B50 Review and Vitamin B50 Label ), ESTER C (View Ester-c Review and Ester-c Label ), GLUCOSAMINE (View Glucosamine Review and Glucosamine Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ), LOVAZA (View Lovaza Review and Lovaza Label ). Patient was hospitalized and became disabled.

6543698-4 | Clostridial Infection
on Jan 11, 2010 Male patient from FRANCE , 57 years of age, was diagnosed with glioblastoma and was treated with Gliadel (View Usage). Patient experienced the following unwanted or unexpected effects: clostridial infection. Gliadel dosage: . During the same period patient was treated with METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), CEFAZOLIN (View Cefazolin Review and Cefazolin Label ).

6460722-8 | Deep Vein Thrombosis
on Nov 25, 2009 Male patient from UNITED STATES , weighting 280.6 lb, was diagnosed with glioblastoma multiforme and was treated with Gliadel (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?). Gliadel dosage: 2 Wafers Once. During the same period patient was treated with TEMODAR (180 Mg Qd Po) (View Temodar Review and Temodar Label ), RADIATION (View Radiation Review and Radiation Label ), PRANDIN (View Prandin Review and Prandin Label ), CEREFOLIN (View Cerefolin Review and Cerefolin Label ), DECADRON (View Decadron Review and Decadron Label ), JANUVIA (View Januvia Review and Januvia Label ), LANTUS (View Lantus Review and Lantus Label ), LEXAPRO (View Lexapro Review and Lexapro Label ). Patient was hospitalized.

6434933-1 | Depressed Level Of Consciousness, Pupil Fixed
Patient was taking Gliadel (View Usage). After Gliadel was administered, patient had the following side effects: depressed level of consciousness, pupil fixed on Nov 09, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 62 years of age, weighting 172.0 lb, was diagnosed with prophylaxis, white blood cell count and. Gliadel dosage: . During the same period patient was treated with PHENYTOIN (View Phenytoin Review and Phenytoin Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ).

6402127-1 | Anaemia, Cognitive Disorder, Dehydration, Hyperglycaemia, Hypoalbuminaemia, Hypokalaemia, Hyponatraemia, Muscular Weakness, Pseudomeningocele
Adverse event was reported on Oct 14, 2009 by a Male patient taking Gliadel (View Usage) (Dosage: ) was diagnosed with glioblastoma and. Location: UNITED STATES , 67 years of age, weighting 189.6 lb, Patient experienced the following unwanted or unexpected effects: anaemia, cognitive disorder, dehydration, hyperglycaemia, hypoalbuminaemia, hypokalaemia, hyponatraemia, muscular weakness, pseudomeningocele. During the same period patient was treated with ATENOLOL (25 Mg Daily) (View Atenolol Review and Atenolol Label ), ZOCOR (40 Mg Daily) (View Zocor Review and Zocor Label ), KEPPRA (View Keppra Review and Keppra Label ), DECADRON (View Decadron Review and Decadron Label ), PEPCID (View Pepcid Review and Pepcid Label ). Patient was hospitalized.

6397803-3 | Anaemia, Cognitive Disorder, Cystic Lymphangioma, Dehydration, Hyperglycaemia, Hypoalbuminaemia, Hypokalaemia, Hyponatraemia, Muscular Weakness
on Oct 09, 2009 Male patient from UNITED STATES , 67 years of age, weighting 189.6 lb, was diagnosed with glioblastoma and was treated with Gliadel (View Usage). Patient had the following side effects: anaemia, cognitive disorder, cystic lymphangioma, dehydration, hyperglycaemia, hypoalbuminaemia, hypokalaemia, hyponatraemia, muscular weakness. Gliadel dosage: . During the same period patient was treated with ATENOLOL (25 Mg Daily) (View Atenolol Review and Atenolol Label ), ZOCOR (40 Mg Daily) (View Zocor Review and Zocor Label ), KEPPRA (View Keppra Review and Keppra Label ), DECADRON (View Decadron Review and Decadron Label ), PEPCID (View Pepcid Review and Pepcid Label ). Patient was hospitalized.

6384955-4 | Anaemia, Cognitive Disorder, Cystic Lymphangioma, Dehydration, Hyperglycaemia, Hyponatraemia, Muscular Weakness, Urinary Tract Infection
on Sep 30, 2009 Male patient from UNITED STATES , 67 years of age, weighting 189.6 lb, was diagnosed with glioblastoma and was treated with Gliadel (View Usage). After Gliadel was administered, patient had the following side effects: anaemia, cognitive disorder, cystic lymphangioma, dehydration, hyperglycaemia, hyponatraemia, muscular weakness, urinary tract infection (What is urinary tract infection?). Gliadel dosage: . During the same period patient was treated with ATENOLOL (25 Mg Daily) (View Atenolol Review and Atenolol Label ), ZOCOR (40 Mg Daily) (View Zocor Review and Zocor Label ), KEPPRA (View Keppra Review and Keppra Label ), DECADRON (View Decadron Review and Decadron Label ), PEPCID (View Pepcid Review and Pepcid Label ). Patient was hospitalized.

6372928-7 | Anaemia, Cognitive Disorder, Cystic Lymphangioma, Dehydration, Hyperglycaemia, Hyponatraemia, Muscular Weakness, Urinary Tract Infection
Patient was taking Gliadel (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, cognitive disorder, cystic lymphangioma, dehydration, hyperglycaemia, hyponatraemia, muscular weakness, urinary tract infection (What is urinary tract infection?) on Sep 22, 2009 from UNITED STATES Additional patient health information: Male patient , 67 years of age, weighting 189.6 lb, was diagnosed with glioblastoma and. Gliadel dosage: . During the same period patient was treated with ATENOLOL (25 Mg Daily) (View Atenolol Review and Atenolol Label ), ZOCOR (40 Mg Daily) (View Zocor Review and Zocor Label ), KEPPRA (View Keppra Review and Keppra Label ), DECADRON (View Decadron Review and Decadron Label ), PEPCID (View Pepcid Review and Pepcid Label ). Patient was hospitalized.

6321712-9 | Asthenia, Convulsion, Dehydration, Non-small Cell Lung Cancer
Adverse event was reported on Aug 20, 2009 by a Female patient taking Gliadel (View Usage) (Dosage: ) was diagnosed with brain cancer metastatic and. Location: UNITED STATES , weighting 103.6 lb, Patient had the following side effects: asthenia, convulsion, dehydration, non-small cell lung cancer. During the same period patient was treated with LEVOXYL (View Levoxyl Review and Levoxyl Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), CALCIUM CITRATE (View Calcium Citrate Review and Calcium Citrate Label ), DOCUSATE/SENNOSIDES (View Docusate/sennosides Review and Docusate/sennosides Label ), FERROUS GLUCONATE (View Ferrous Gluconate Review and Ferrous Gluconate Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), ALUMINUM HYDROXIDE GEL (View Aluminum Hydroxide Gel Review and Aluminum Hydroxide Gel Label ), BISACODYL (View Bisacodyl Review and Bisacodyl Label ). Patient was hospitalized.

6311742-5 | Asthenia, Convulsion, Dehydration, Non-small Cell Lung Cancer
on Aug 17, 2009 Female patient from UNITED STATES , weighting 101.4 lb, was diagnosed with brain cancer metastatic and was treated with Gliadel (View Usage). After Gliadel was administered, patient had the following side effects: asthenia, convulsion, dehydration, non-small cell lung cancer. Gliadel dosage: . During the same period patient was treated with LEVOXYL (View Levoxyl Review and Levoxyl Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), CALCIUM CITRATE (View Calcium Citrate Review and Calcium Citrate Label ), DOCUSATE/SENNOSIDES (View Docusate/sennosides Review and Docusate/sennosides Label ), FERROUS GLUCONATE (View Ferrous Gluconate Review and Ferrous Gluconate Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), ALUMINUM HYDROXIDE GEL (View Aluminum Hydroxide Gel Review and Aluminum Hydroxide Gel Label ), BISACODYL (View Bisacodyl Review and Bisacodyl Label ). Patient was hospitalized.

6212071-0 | Intracranial Hypotension, Soft Tissue Necrosis
on Jun 02, 2009 Female patient from UNITED STATES , weighting 134.5 lb, was treated with Gliadel (View Usage). Patient experienced the following unwanted or unexpected effects: intracranial hypotension, soft tissue necrosis. Gliadel dosage: . During the same period patient was treated with LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), DYAZIDE (View Dyazide Review and Dyazide Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), MONTELUKAST (View Montelukast Review and Montelukast Label ), COLACE (View Colace Review and Colace Label ), PROTONIX (View Protonix Review and Protonix Label ), CETIRIZINE (View Cetirizine Review and Cetirizine Label ). Patient was hospitalized.

6181714-2 | Asthenia, Convulsion, Dehydration, Non-small Cell Lung Cancer
Patient was taking Gliadel (View Usage). Patient had the following side effects: asthenia, convulsion, dehydration, non-small cell lung cancer on May 04, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 101.4 lb, was diagnosed with brain cancer metastatic and. Gliadel dosage: . During the same period patient was treated with LEVOXYL (View Levoxyl Review and Levoxyl Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), CALCIUM CITRATE (View Calcium Citrate Review and Calcium Citrate Label ), DOCUSATE/SENNOSIDES (View Docusate/sennosides Review and Docusate/sennosides Label ), FERROUS GLUCONATE (View Ferrous Gluconate Review and Ferrous Gluconate Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), ALUMINUM HYDROXIDE GEL (View Aluminum Hydroxide Gel Review and Aluminum Hydroxide Gel Label ), BISACODYL (View Bisacodyl Review and Bisacodyl Label ). Patient was hospitalized.

6173010-4 | Asthenia, Convulsion, Dehydration, Non-small Cell Lung Cancer
Adverse event was reported on Apr 23, 2009 by a Female patient taking Gliadel (View Usage) (Dosage: ) was diagnosed with brain cancer metastatic and. Location: UNITED STATES , weighting 101.4 lb, After Gliadel was administered, patient had the following side effects: asthenia, convulsion, dehydration, non-small cell lung cancer. During the same period patient was treated with LEVOXYL (View Levoxyl Review and Levoxyl Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), CALCIUM CITRATE (View Calcium Citrate Review and Calcium Citrate Label ), DOCUSATE/SENNOSIDES (View Docusate/sennosides Review and Docusate/sennosides Label ), FERROUS GLUCONATE (View Ferrous Gluconate Review and Ferrous Gluconate Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), ALUMINUM HYDROXIDE GEL (View Aluminum Hydroxide Gel Review and Aluminum Hydroxide Gel Label ), BISACODYL (View Bisacodyl Review and Bisacodyl Label ). Patient was hospitalized.

6167193-X | Asthenia, Dehydration, Non-small Cell Lung Cancer
on Apr 14, 2009 Male patient from UNITED STATES , weighting 101.4 lb, was diagnosed with brain cancer metastatic and was treated with Gliadel (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, dehydration, non-small cell lung cancer. Gliadel dosage: . During the same period patient was treated with LEVOXYL (View Levoxyl Review and Levoxyl Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), CALCIUM CITRATE (View Calcium Citrate Review and Calcium Citrate Label ), DOCUSATE/SENNOSIDES (View Docusate/sennosides Review and Docusate/sennosides Label ), FERROUS GLUCONATE (View Ferrous Gluconate Review and Ferrous Gluconate Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), ALUMINUM HYDROXIDE GEL (View Aluminum Hydroxide Gel Review and Aluminum Hydroxide Gel Label ), BISACODYL (View Bisacodyl Review and Bisacodyl Label ). Patient was hospitalized.

6143039-0 | Meningitis
on Apr 01, 2009 Female patient from FRANCE , 44 years of age, was diagnosed with mixed oligo-astrocytoma and was treated with Gliadel (View Usage). Patient had the following side effects: meningitis (What is meningitis?). Gliadel dosage: .

6070136-0 | Alpha Haemolytic Streptococcal Infection, Blood Calcium Decreased, Blood Magnesium Decreased, Blood Phosphorus Decreased, Blood Potassium Decreased, Csf Culture Positive, Intracranial Hypotension, Soft Tissue Necrosis, Subdural Hygroma
Patient was taking Gliadel (View Usage). After Gliadel was administered, patient had the following side effects: alpha haemolytic streptococcal infection, blood calcium decreased, blood magnesium decreased, blood phosphorus decreased, blood potassium decreased, csf culture positive, intracranial hypotension, soft tissue necrosis, subdural hygroma on Feb 06, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 134.5 lb, was diagnosed with brain neoplasm and. Gliadel dosage: . Patient was hospitalized.

5982973-9 | Aplastic Anaemia
Adverse event was reported on Nov 30, 2007 by a Female patient taking Gliadel (View Usage) (Dosage: 38.5 Mg;1x;icer) was diagnosed with glioblastoma multiforme and. Location: UNITED STATES , 60 years of age, weighting 154.0 lb, Patient experienced the following unwanted or unexpected effects: aplastic anaemia. During the same period patient was treated with TEMOZOLOMIDE (130 Mg;qd;po) (View Temozolomide Review and Temozolomide Label ), POLYGAM S/D (View Polygam S/d Review and Polygam S/d Label ), PLATELETS (View Platelets Review and Platelets Label ).

5982969-7 | Deep Vein Thrombosis, Pulmonary Embolism
on Nov 30, 2007 Female patient from UNITED STATES , 59 years of age, weighting 154.0 lb, was diagnosed with glioblastoma multiforme and was treated with Gliadel (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), pulmonary embolism (What is pulmonary embolism?). Gliadel dosage: 38.5 Mg;1x;icer. During the same period patient was treated with TEMOZOLOMIDE (130 Mg;qd;po) (View Temozolomide Review and Temozolomide Label ). Patient was hospitalized.

5982958-2 | Rash, Urinary Tract Infection
on Sep 17, 2008 Female patient from UNITED STATES , 61 years of age, weighting 171.0 lb, was diagnosed with astrocytoma and was treated with Gliadel (View Usage). After Gliadel was administered, patient had the following side effects: rash (What is rash?), urinary tract infection (What is urinary tract infection?). Gliadel dosage: 61.6 Mg;x1;icer. During the same period patient was treated with TEMODAR (View Temodar Review and Temodar Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), KEPPRA (View Keppra Review and Keppra Label ), DECADRON (View Decadron Review and Decadron Label ), PEPCID (View Pepcid Review and Pepcid Label ). Patient was hospitalized.

5982956-9 | Agitation, Confusional State
Patient was taking Gliadel (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, confusional state on Aug 18, 2008 from UNITED STATES Additional patient health information: Male patient , 82 years of age, weighting 215.0 lb, was diagnosed with brain neoplasm and. Gliadel dosage: 61.6 Mg;x1;icer. Patient was hospitalized.

5982953-3 | Dyspnoea, Pyrexia, Rash Macular
Adverse event was reported on Aug 06, 2008 by a Male patient taking Gliadel (View Usage) (Dosage: 23.1 Mg;x1;icer) was diagnosed with glioblastoma multiforme and. Location: UNITED STATES , 41 years of age, weighting 212.0 lb, Patient had the following side effects: dyspnoea, pyrexia, rash macular. During the same period patient was treated with DENDRITIC CELL VACCINE (X1;intradermal) (View Dendritic Cell Vaccine Review and Dendritic Cell Vaccine Label ). Patient was hospitalized.

5982931-4 | Aphasia
on Nov 14, 2007 Male patient from UNITED STATES , 53 years of age, was diagnosed with glioblastoma multiforme and was treated with Gliadel (View Usage). After Gliadel was administered, patient had the following side effects: aphasia (What is aphasia?). Gliadel dosage: X1;icer. During the same period patient was treated with DECADRON (View Decadron Review and Decadron Label ), DILANTIN (View Dilantin Review and Dilantin Label ). Patient was hospitalized.

5982927-2 | Metastases To Spine
on Nov 08, 2007 Female patient from UNITED STATES , 15 years of age, was diagnosed with glioblastoma multiforme and was treated with Gliadel (View Usage). Patient experienced the following unwanted or unexpected effects: metastases to spine. Gliadel dosage: 1x;icer.

5982925-9 | Thrombocytopenia
Patient was taking Gliadel (View Usage). Patient had the following side effects: thrombocytopenia on Oct 09, 2007 from UNITED STATES Additional patient health information: Female patient , 60 years of age, weighting 154.0 lb, was diagnosed with glioblastoma multiforme and. Gliadel dosage: 38.5 Mg;x1;icer. During the same period patient was treated with TEMOZOLOMIDE (130 Mg;qd;po) (View Temozolomide Review and Temozolomide Label ).

5982901-6 | Intracranial Hypotension, Off Label Use, Postoperative Wound Infection
Adverse event was reported on Jul 08, 2008 by a Male patient taking Gliadel (View Usage) (Dosage: X1;icer) was diagnosed with metastases to central nervous system and. Location: UNITED STATES , 63 years of age, After Gliadel was administered, patient had the following side effects: intracranial hypotension, off label use, postoperative wound infection. During the same period patient was treated with AVODART (View Avodart Review and Avodart Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), M.V.I. (View M.v.i. Review and M.v.i. Label ), REMERON (View Remeron Review and Remeron Label ), SPIRIVA (View Spiriva Review and Spiriva Label ). Patient was hospitalized.

5982896-5 | Disease Progression, Off Label Use
on Dec 05, 2006 Male patient from UNITED STATES , 38 years of age, was diagnosed with metastases to spine and was treated with Gliadel (View Usage). Patient experienced the following unwanted or unexpected effects: disease progression, off label use. Gliadel dosage: 23.1 Mg;x1;icav.

5982881-3 | Disease Progression, Off Label Use
on Dec 05, 2008 Female patient from UNITED STATES , 46 years of age, was diagnosed with metastases to spine and was treated with Gliadel (View Usage). Patient had the following side effects: disease progression, off label use. Gliadel dosage: 15.4 Mg;x1;icav.

5982834-5 | Brain Oedema, Meningitis, Off Label Use
Patient was taking Gliadel (View Usage). After Gliadel was administered, patient had the following side effects: brain oedema, meningitis (What is meningitis?), off label use on Mar 12, 2008 from UNITED STATES Additional patient health information: Male patient , 38 years of age, was diagnosed with anaplastic astrocytoma and. Gliadel dosage: 1x;icer. Patient was hospitalized.

5940399-8 | Csf Protein Increased, Depressed Level Of Consciousness, Meningism
Adverse event was reported on Oct 28, 2008 by a Male patient taking Gliadel (View Usage) (Dosage: ) was diagnosed with glioma and. Location: FRANCE , 64 years of age, Patient experienced the following unwanted or unexpected effects: csf protein increased, depressed level of consciousness, meningism.

5818344-5 | Bradycardia, Fibrin D Dimer Increased, Hypoxia
on Jun 27, 2008 Male patient from ITALY , 48 years of age, was diagnosed with glioblastoma and was treated with Gliadel (View Usage). Patient had the following side effects: bradycardia, fibrin d dimer increased, hypoxia. Gliadel dosage: 53.9 Mg;x1; Icer. Patient was hospitalized.

5789471-6 | Bradycardia, Hypoxia
on Jun 12, 2008 Male patient from ITALY , 48 years of age, was diagnosed with glioblastoma and was treated with Gliadel (View Usage). After Gliadel was administered, patient had the following side effects: bradycardia, hypoxia. Gliadel dosage: X1;icer. Patient was hospitalized.

5752990-2 | Brain Oedema, Neurological Symptom, Treatment Failure
Patient was taking Gliadel (View Usage). Patient experienced the following unwanted or unexpected effects: brain oedema, neurological symptom, treatment failure on May 14, 2008 from SPAIN Additional patient health information: Male patient , 41 years of age, was diagnosed with glioblastoma multiforme and. Gliadel dosage: 61.6 Mg,1x;icer. During the same period patient was treated with TEMOZOLOMIDE (View Temozolomide Review and Temozolomide Label ). Patient was hospitalized.

5744865-X | Neoplasm Recurrence, Nervous System Disorder
Adverse event was reported on Apr 25, 2008 by a Female patient taking Gliadel (View Usage) (Dosage: 1x; Icer) was diagnosed with ependymoma malignant and. Location: ITALY , 15 years of age, Patient had the following side effects: neoplasm recurrence, nervous system disorder.

5711792-3 | Brain Oedema, Cerebral Ischaemia, Coma, Decubitus Ulcer, Intracranial Pressure Increased, Ischaemic Stroke, Mydriasis
on Nov 25, 2007 Female patient from FRANCE , 43 years of age, weighting 136.7 lb, was diagnosed with glioblastoma and was treated with Gliadel (View Usage). After Gliadel was administered, patient had the following side effects: brain oedema, cerebral ischaemia, coma, decubitus ulcer, intracranial pressure increased, ischaemic stroke, mydriasis. Gliadel dosage: 61.6 Mg; X1; Icer.

5710852-0 | Cns Ventriculitis, Meningitis Chemical, Wound Infection
on Apr 02, 2008 Male patient from UNITED KINGDOM , 69 years of age, was treated with Gliadel (View Usage). Patient experienced the following unwanted or unexpected effects: cns ventriculitis, meningitis chemical, wound infection. Gliadel dosage: 1x; Icer. Patient was hospitalized.

5701521-1 | Brain Oedema, Cerebral Ischaemia, Coma, Decubitus Ulcer, Post Procedural Oedema
Patient was taking Gliadel (View Usage). Patient had the following side effects: brain oedema, cerebral ischaemia, coma, decubitus ulcer, post procedural oedema on Nov 25, 2007 from FRANCE Additional patient health information: Female patient , 43 years of age, weighting 136.7 lb, was diagnosed with glioblastoma and. Gliadel dosage: 61.6 Mg; X1; Icer.